Table 4.
Marker
|
AUC
|
Specificity at 90% sensitivity
|
Comparison
|
PIVKA-II | 0.83 | 34 | All HCC vs CLD |
PIVKA-II + miRNAs | 0.87 | 48 | |
PIVKA-II | 0.70 | 15 | Early HCC vs CLD |
PIVKA-II + miRNAs | 0.74 | 29 | |
PIVKA-II | 0.64 | 12 | Early HCC vs cirrhosis |
PIVKA-II + miRNAs | 0.71 | 42 |
Area under the curve and specificity at 90% sensitivity for Protein induced by vitamin K absence/antagonist-II alone and in combination with the 26 selected miRNAs, resulting from the logistic regression model. AUC: Area under the curve; CLD: Chronic liver disease; HCC: Hepatocellular carcinoma; miRNA: MicroRNA; PIVKA-II: Protein induced by vitamin K absence/antagonist-II.